Indeed, they proposed that activation of Nrf2 resulted in FXR-mediated induction of Shp, which subsequently inhibited LXRα by forming an inactive LXRα-Shp heterodimer, and prevented T0901317 from stimulating NASH. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.